Skip to content
2000
Volume 16, Issue 3
  • ISSN: 2210-3155
  • E-ISSN: 2210-3163

Abstract

The lack of melanin-producing cells in the epidermis causes white patches to develop in vitiligo, a chronic skin disorder. Although vitiligo seldom causes physical injury, it can have serious psychological and social consequences, such as diminished self-confidence and feelings of inadequacy. While there is no known cure for vitiligo, there are several treatments that can help control the illness and lessen its impact on people's lives. In this review, we take a look at the literature on phytoconstituents and plant extracts as prospective therapeutic agents for vitiligo. Traditional medicine has a long history of using plant extracts for the treatment of many ailments, including skin diseases. The pharmacological effects of natural bioactive substances are diverse, including antioxidant, anti-inflammatory, and immunomodulatory capabilities. For this reason, they hold great promise as a vitiligo cure.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/npj/10.2174/0122103155337960241205070806
2025-01-15
2026-02-27

  • From This Site

    /content/journals/npj/10.2174/0122103155337960241205070806
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SinghS. ChaudharyA. PatelM. Current debates on etiopathogenesis and treatment strategies for vitiligo.Curr. Drug Targets202223131219123810.2174/138945012366622040612564535388753
     [Google Scholar]
  2. NingX. ZhangY. WangW. YanH. The association between social support and depression among patients with vitiligo in China.Front. Psychol.20221393984510.3389/fpsyg.2022.93984536081711
     [Google Scholar]
  3. AklJ LeeS JuHJ ParisiR KimJY JeonJJ HeoYW EleftheriadouV HamzaviI GriffithsCEM AshcroftDM MysoreV GuptaS ParsadD LimH BaeJM EzzedineK Estimating the burden of vitiligo: A systematic review and modelling study.Lancet Public Health202496S2468S266710.1016/S2468‑2667(24)00026‑4
     [Google Scholar]
  4. MitevaM. VillasanteA. Epidemiology and burden of alopecia areata: A systematic review.Clin. Cosmet. Investig. Dermatol.2015839740310.2147/CCID.S5398526244028
     [Google Scholar]
  5. GiriP. DesaiD. DwivediM. Animal models unraveling the complexity of vitiligo pathogenesis.Autoimmun. Rev.2024234103515Epub ahead of print10.1016/j.autrev.2024.10351538185189
     [Google Scholar]
  6. BergqvistC. EzzedineK. Vitiligo: A focus on pathogenesis and its therapeutic implications.J. Dermatol.202148325227010.1111/1346‑8138.1574333404102
     [Google Scholar]
  7. de BaatC. Medicaments and oral healthcare. Hyperpigmentation of oral soft tissues due to afamelanotide.Ned. Tijdschr. Tandheelkd.202012723724310.5177/ntvt.2020.04.19115
     [Google Scholar]
  8. BishnoiA. ParsadD. Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature.Photodermatol. Photoimmunol. Photomed.2024403e1296810.1111/phpp.1296838632705
     [Google Scholar]
  9. RazmiT M ParsadD. Recent advances in pathogenesis and medical management of vitiligo.Pigmentary Skin Disorders; Springer: Cham201810.1007/978‑3‑319‑70419‑7_8
     [Google Scholar]
  10. OhS.H. HannS-K. Classification and Clinical Features of Vitiligo; Vitiligo2018334710.1002/9781118937303.ch6
     [Google Scholar]
  11. IwanowskiT. SzlązakP. ZabłotnaM. OlszewskaB. Sokołowska-WojdyłoM. Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Polish.Postepy Dermatol. Alergol.202138463664310.5114/ada.2021.10889634658707
     [Google Scholar]
  12. MarchioroH.Z. Silva de CastroC.C. FavaV.M. SakiyamaP.H. DellatorreG. MiotH.A. Update on the pathogenesis of vitiligo.An. Bras. Dermatol.202297447849010.1016/j.abd.2021.09.00835643735
     [Google Scholar]
  13. SinghS. SinghU. PandeyS.S. Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients.Indian J. Dermatol.2012571121410.4103/0019‑5154.9266822470201
     [Google Scholar]
  14. AbdelmaksoudA. Methotrexate for treatment of vitiligo.Dermatol. Ther.2017306e1253210.1111/dth.1253228796400
     [Google Scholar]
  15. KAL-smadi Vitiligo: A review of aetiology, pathogenesis, treatment, and psychosocial impact.Cosmetics20231038410.3390/cosmetics10030084
     [Google Scholar]
  16. NatarelliN NongY MalohJ SivamaniR. Topical integrative approaches to vitiligo: A systematic review.J. Integr. Dermatol.2023
     [Google Scholar]
  17. PangY. WuS. HeY. NianQ. LeiJ. YaoY. GuoJ. ZengJ. Plant-derived compounds as promising therapeutics for vitiligo.Front. Pharmacol.20211268511610.3389/fphar.2021.68511634858164
     [Google Scholar]
  18. ShinS.W. JungE. KimS. KimJ.H. KimE.G. LeeJ. ParkD. Antagonizing effects and mechanisms of afzelin against UVB-induced cell damage.PLoS One201384e6197110.1371/journal.pone.006197123626759
     [Google Scholar]
  19. JungE. KimJ.H. KimM.O. JangS. KangM. OhS.W. NhoY.H. KangS.H. KimM.H. ParkS.H. LeeJ. Afzelin positively regulates melanogenesis through the p38 MAPK pathway.Chem. Biol. Interact.201625416717210.1016/j.cbi.2016.06.01027287415
     [Google Scholar]
  20. JungE. KimJ.H. KimM.O. LeeS.Y. LeeJ. Melanocyte‐protective effect of afzelin is mediated by the Nrf2‐ ARE signalling pathway via GSK ‐3β inactivation.Exp. Dermatol.201726976477010.1111/exd.1327727992083
     [Google Scholar]
  21. LiuR. JiP. LiuB. QiaoH. WangX. ZhouL. DengT. BaY. Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis.Oncol. Lett.20171321024103010.3892/ol.2016.549528356995
     [Google Scholar]
  22. HanY. ZhangT. SuJ. ZhaoY. Chenchen, Wang, LiX. Apigenin attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage.J. Clin. Neurosci.20174015716210.1016/j.jocn.2017.03.00328342702
     [Google Scholar]
  23. BaekJ. LeeM.G. Oxidative stress and antioxidant strategies in dermatology.Redox Rep.201621416416910.1179/1351000215Y.000000001526020527
     [Google Scholar]
  24. PanieriE. Telkoparan-AkillilarP. SasoL. NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer.Biofactors202349222825010.1002/biof.191236310374
     [Google Scholar]
  25. ZhangB. WangJ. ZhaoG. LinM. LangY. ZhangD. FengD. TuC. Apigenin protects human melanocytes against oxidative damage by activation of the Nrf2 pathway.Cell Stress Chaperones202025227728510.1007/s12192‑020‑01071‑731953635
     [Google Scholar]
  26. LinM. LuS. WangA. QiX. ZhaoD. WangZ. ManM.Q. TuC. Apigenin attenuates dopamine-induced apoptosis in melanocytes via oxidative stress-related p38, c-Jun NH2-terminal kinase and Akt signaling.J. Dermatol. Sci.2011631101610.1016/j.jdermsci.2011.03.00721514118
     [Google Scholar]
  27. TakekoshiS. NagataH. KitataniK. Flavonoids enhance melanogenesis in human melanoma cells.Tokai J. Exp. Clin. Med.201439311612125248426
     [Google Scholar]
  28. ShuklaS GuptaS. Apigenin: A promising molecule for cancer prevention.Pharm. Res.201027696297810.1007/s11095‑010‑0089‑7
     [Google Scholar]
  29. KimJ.K. KimY.S. KimY. UddinM.R. KimY.B. KimH.H. ParkS.Y. LeeM.Y. ChungS.O. ParkS.U. Comparative analysis of flavonoids and polar metabolites from hairy roots of Scutellaria baicalensis and Scutellaria lateriflora.World J. Microbiol. Biotechnol.201430388789210.1007/s11274‑013‑1498‑724162949
     [Google Scholar]
  30. ChoiE.O. JeongJ.W. ParkC. HongS.H. KimG.Y. HwangH.J. ChoE.J. ChoiY.H. Baicalein protects C6 glial cells against hydrogen peroxide-induced oxidative stress and apoptosis through regulation of the Nrf2 signaling pathway.Int. J. Mol. Med.201637379880610.3892/ijmm.2016.246026796879
     [Google Scholar]
  31. ZhaoW.Z. WangH.T. HuangH.J. LoY.L. LinA.M.Y. Neuroprotective effects of baicalein on acrolein-induced neurotoxicity in the nigrostriatal dopaminergic system of rat brain.Mol. Neurobiol.201855113013710.1007/s12035‑017‑0725‑x28866823
     [Google Scholar]
  32. MaJ. LiS. ZhuL. GuoS. YiX. CuiT. HeY. ChangY. LiuB. LiC. JianZ. Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway.Free Radic. Biol. Med.201812949250310.1016/j.freeradbiomed.2018.10.42130342186
     [Google Scholar]
  33. VaccaroM. IrreraN. CutroneoG. RizzoG. VaccaroF. AnastasiG. BorgiaF. CannavòS. AltavillaD. SquadritoF. Differential expression of nitric oxide synthase isoforms nNOS and iNOS in patients with non-segmental generalized vitiligo.Int. J. Mol. Sci.20171812253310.3390/ijms1812253329186858
     [Google Scholar]
  34. LiuB. JianZ. LiQ. LiK. WangZ. LiuL. TangL. YiX. WangH. LiC. GaoT. Baicalein protects human melanocytes from H2O2-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway.Free Radic. Biol. Med.201253218319310.1016/j.freeradbiomed.2012.04.01522569306
     [Google Scholar]
  35. WuJ. ZhouM. WanY. XuA. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.Mol. Med. Rep.20137123724110.3892/mmr.2012.111723042234
     [Google Scholar]
  36. ZhuY. ZhongL. PengJ. YuanQ. XuA. The therapeutic effects of baicalin on vitiligo mice.Biol. Pharm. Bull.20194291450145510.1248/bpb.b19‑0031931217369
     [Google Scholar]
  37. IuvoneT. EspositoG. De FilippisD. ScuderiC. SteardoL. Cannabidiol: A promising drug for neurodegenerative disorders?CNS Neurosci. Ther.2009151657510.1111/j.1755‑5949.2008.00065.x19228180
     [Google Scholar]
  38. BaswanS.M. KlosnerA.E. GlynnK. RajgopalA. MalikK. YimS. SternN. Therapeutic potential of cannabidiol (CBD) for skin health and disorders.Clin. Cosmet. Investig. Dermatol.20201392794210.2147/CCID.S28641133335413
     [Google Scholar]
  39. HwangY.S. KimY.J. KimM.O. KangM. OhS.W. NhoY.H. ParkS.H. LeeJ. Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK.Chem. Biol. Interact.201727310711410.1016/j.cbi.2017.06.00528601556
     [Google Scholar]
  40. AtalayS. Jarocka-KarpowiczI. SkrzydlewskaE. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants2019912110.3390/antiox901002131881765
     [Google Scholar]
  41. SzabóI.L. LisztesE. BékeG. TóthK.F. PausR. OláhA. BíróT. The phytocannabinoid (–)-cannabidiol operates as a complex, differential modulator of human hair growth: Anti-inflammatory submicromolar versus hair growth inhibitory micromolar effects.J. Invest. Dermatol.20201402484488.e510.1016/j.jid.2019.07.69031369737
     [Google Scholar]
  42. JastrząbA. Jarocka-KarpowiczI. MarkowskaA. WrońskiA. GęgotekA. SkrzydlewskaE. Antioxidant and anti‐inflammatory effect of cannabidiol contributes to the decreased lipid peroxidation of keratinocytes of rat skin exposed to UV radiation.Oxid. Med. Cell. Longev.202120211664722210.1155/2021/6647222
     [Google Scholar]
  43. BiernackiM. BrzóskaM.M. MarkowskaA. Gałażyn-SidorczukM. CylwikB. GęgotekA. SkrzydlewskaE. Oxidative stress and its consequences in the blood of rats irradiated with UV: Protective effect of cannabidiol. Antioxidants202110682110.3390/antiox1006082134063802
     [Google Scholar]
  44. PaudelK.S. HammellD.C. AguR.U. ValivetiS. StinchcombA.L. Cannabidiol bioavailability after nasal and transdermal application: Effect of permeation enhancers.Drug Dev. Ind. Pharm.20103691088109710.3109/03639041003657295
     [Google Scholar]
  45. HuangK. LiC. GaoF. FanY. ZengF. MengL. LiL. ZhangS. WeiH. Epigallocatechin-3-gallate promotes the in vitro maturation and embryo development following IVF of porcine oocytes.Drug Des. Devel. Ther.2021151013102010.2147/DDDT.S29593633707939
     [Google Scholar]
  46. ZhuY. WangS. LinF. LiQ. XuA. The therapeutic effects of EGCG on vitiligo.Fitoterapia20149924325110.1016/j.fitote.2014.08.00725128425
     [Google Scholar]
  47. HuW. ZhangL. LinF. LeiJ. ZhouM. XuA. Topical epigallocatechin‐3‐gallate in the treatment of vitiligo.Australas. J. Dermatol.2021623e404e40710.1111/ajd.1361234046892
     [Google Scholar]
  48. KatiyarS.K. MatsuiM.S. ElmetsC.A. MukhtarH. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.Photochem. Photobiol.199969214815310.1562/0031‑8655(1999)069<0148:PAEGFG>2.3.CO;210048310
     [Google Scholar]
  49. MaouiaA. SormaniL. YoussefM. HelalA.N. KassabA. PasseronT. Differential expression of CXCL 9, CXCL 10, and IFN ‐ γ in vitiligo and alopecia areata patients.Pigment Cell Melanoma Res.201730225926110.1111/pcmr.1255927863059
     [Google Scholar]
  50. WangJ. LiP. QinT. SunD. ZhaoX. ZhangB. Protective effect of epigallocatechin‐3‐gallate against neuroinflammation and anxiety‐like behavior in a rat model of myocardial infarction.Brain Behav.2020106e0163310.1002/brb3.163332304289
     [Google Scholar]
  51. NingW. WangS. DongX. LiuD. FuL. JinR. XuA. Epigallocatechin-3-gallate (EGCG) suppresses the trafficking of lymphocytes to epidermal melanocytes via inhibition of JAK2: Its implication for vitiligo treatment.Biol. Pharm. Bull.201538111700170610.1248/bpb.b15‑0033126345342
     [Google Scholar]
  52. NingW. WangS. LiuD. FuL. JinR. XuA. Potent effects of peracetylated (-)-epigallocatechin-3-gallate against hydrogen peroxide-induced damage in human epidermal melanocytes via attenuation of oxidative stress and apoptosis.Clin. Exp. Dermatol.201641661662410.1111/ced.1285527339454
     [Google Scholar]
  53. KhanH. Marya, AminS. KamalM.A. PatelS. Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects.Biomed. Pharmacother.201810186087010.1016/j.biopha.2018.03.00729635895
     [Google Scholar]
  54. ImranM. SaeedF. GilaniS.A. ShariatiM.A. ImranA. AfzaalM. AtifM. TufailT. AnjumF.M. Fisetin: An anticancer perspective.Food Sci. Nutr.20219131610.1002/fsn3.187233473265
     [Google Scholar]
  55. GrynkiewiczG. DemchukO.M. New Perspectives for Fisetin. Front Chem.2019769710.3389/fchem.2019.0069731750288
     [Google Scholar]
  56. MolagodaI.M.N. KarunarathneW.A.H.M. ParkS.R. ChoiY.H. ParkE.K. JinC.Y. YuH. JoW.S. LeeK.T. KimG.Y. GSK-3β-targeting fisetin promotes melanogenesis in B16F10 melanoma cells and zebrafish larvae through β-catenin activation.Int. J. Mol. Sci.202021131210.3390/ijms2101031231906440
     [Google Scholar]
  57. YangCC. LinCC. HsiaoL. Der, YangCM. Galangin inhibits thrombin-induced MMP-9 expression in SK-N-SH cells via protein kinase-dependent NF-κB phosphorylation.Int. J. Mol. Sci.20181912408410.3390/ijms19124084
     [Google Scholar]
  58. SkibaM.A. SzendzielorzK. MazurB. KrólW. The inhibitory effect of flavonoids on interleukin-8 release by human gastric adenocarcinoma (AGS) cells infected with cag PAI (+) Helicobacter pylori. Cent. Eur. J. Immunol.20163322923510.5114/ceji.2016.6311927833438
     [Google Scholar]
  59. MaY.L. ZhaoF. YinJ.T. LiangC.J. NiuX.L. QiuZ.H. ZhangL.T. Two approaches for evaluating the effects of galangin on the activities and mRNA expression of seven CYP450.Molecules2019246117110.3390/molecules2406117130934565
     [Google Scholar]
  60. CushnieT.P.T. HamiltonV.E.S. ChapmanD.G. TaylorP.W. LambA.J. Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin. J. Appl. Microbiol.200710351562156710.1111/j.1365‑2672.2007.03393.x17953567
     [Google Scholar]
  61. SinhaR. SrivastavaS. JoshiA. JoshiU.J. GovilG. In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: Role of localization and intermolecular interaction in model membrane.Eur. J. Med. Chem.20147910210910.1016/j.ejmech.2014.04.00224727463
     [Google Scholar]
  62. HuoS.X. LiuX.M. GeC.H. GaoL. PengX.M. ZhaoP.P. YanM. The effects of galangin on a mouse model of vitiligo induced by hydroquinone.Phytother. Res.201428101533153810.1002/ptr.516124820380
     [Google Scholar]
  63. FangD. XiongZ. XuJ. YinJ. LuoR. Chemopreventive mechanisms of galangin against hepatocellular carcinoma: A review.Biomed. Pharmacother.20191092054206110.1016/j.biopha.2018.09.15430551461
     [Google Scholar]
  64. CaiX. WangX. LiJ. ChenS. Protective effect of glycyrrhizin on myocardial ischemia/reperfusion injury-induced oxidative stress, inducible nitric oxide synthase and inflammatory reactions through high-mobility group box 1 and mitogen-activated protein kinase expression.Exp. Ther. Med.20171421219122610.3892/etm.2017.461728810581
     [Google Scholar]
  65. LiM. XiangL. LiY. Efficacy and safety of compound glycyrrhizin in the patients with vitiligo: A systematic review and meta-analysis.Expert Rev. Clin. Pharmacol.202316660161110.1080/17512433.2023.221388737218470
     [Google Scholar]
  66. AllamM. RiadH. Concise review of recent studies in vitiligo.Qatar Med. J.20142013211910.5339/qmj.2013.1025003059
     [Google Scholar]
  67. MouK.H. HanD. LiuW.L. LiP. Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo.Braz. J. Med. Biol. Res.2016498e535410.1590/1414‑431x2016535427464024
     [Google Scholar]
  68. AliSA. ParveenN. AliAS. Promoting Melanocyte Regeneration Using Different Plants and Their Constituents; Bentham Science Publishers201910.2174/9789811411205119030010
     [Google Scholar]
  69. WangQ. WeiH.C. ZhouS.J. LiY. ZhengT.T. ZhouC.Z. WanX.H. Hyperoside: A review on its sources, biological activities, and molecular mechanisms.Phytother. Res.20223672779280210.1002/ptr.747835561084
     [Google Scholar]
  70. YangB. YangQ. YanH-B. YangX. LuQ-P. Hyperoside elevates the melanin content and promotes the migration of human melanocytes.Int. J. Clin. Exp. Med.20171029532959
     [Google Scholar]
  71. YangB. YangQ. YangX. YanH.B. LuQ.P. Hyperoside protects human primary melanocytes against H2O2-induced oxidative damage.Mol. Med. Rep.20161364613461910.3892/mmr.2016.510727082158
     [Google Scholar]
  72. LiuZ.Q. YaoG.L. ZhaiJ.M. HuD.W. FanY.G. Kaempferol suppresses proliferation and induces apoptosis and DNA damage in human gallbladder cancer cells through the CDK4/CDK6/cyclin D1 pathway.Eur. Rev. Med. Pharmacol. Sci.20212531311132110.26355/EURREV_202102_2483633629301
     [Google Scholar]
  73. Calderon-Montano JM. A review on the dietary flavonoid Kaempferol. Mini Rev. Med. Chem.20111129834410.2174/138955711795305335
     [Google Scholar]
  74. WangJ.Y. ChenH. WangY.Y. WangX.Q. ChenH.Y. ZhangM. TangY. ZhangB. Network pharmacological mechanisms of Vernonia anthelmintica (L.) in the treatment of vitiligo: Isorhamnetin induction of melanogenesis via up-regulation of melanin-biosynthetic genes.BMC Syst. Biol.201711110310.1186/s12918‑017‑0486‑129145845
     [Google Scholar]
  75. TangH. YangL. WuL. WangH. ChenK. WuH. LiY. Kaempferol, the melanogenic component of Sanguisorba officinalis, enhances dendricity and melanosome maturation/transport in melanocytes.J. Pharmacol. Sci.2021147434835710.1016/j.jphs.2021.08.00934663517
     [Google Scholar]
  76. GaoW. WangW. PengY. DengZ. Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of AKT/β-catenin cascade.Metab. Brain Dis.201934248549410.1007/s11011‑019‑0389‑530762138
     [Google Scholar]
  77. XieY. MeiX. ShiW. Kaempferol promotes melanogenesis and reduces oxidative stress in PIG1 normal human skin melanocytes.J. Cell. Mol. Med.202327798299010.1111/jcmm.1771136924030
     [Google Scholar]
  78. GianfaldoniS. WollinaU. TirantM. TchernevG. LottiJ. SatolliF. RovestiM. FrançaK. LottiT. Herbal compounds for the treatment of vitiligo: A review.Open Access Maced. J. Med. Sci.20186120320710.3889/oamjms.2018.04829484024
     [Google Scholar]
  79. PereiraJ. GonçalvesR. BarretoM. DiasC. CarvalhoF. AlmeidaA.J. RibeiroH.M. MartoJ. Development of gel-in-oil emulsions for khellin topical delivery.Pharmaceutics202012539810.3390/pharmaceutics1205039832357441
     [Google Scholar]
  80. FennicheS. ZaouakA. TanfousA.B. JradM. HammamiH. Successful treatment of refractory vitiligo with a combination of khellin and 308-nm excimer lamp: An open-label, 1-year prospective study.Dermatol. Ther. (Heidelb.)20188112713510.1007/s13555‑017‑0218‑x29282672
     [Google Scholar]
  81. AbdelqaderN. MakkiM. Abdel-AleemH. Monochromatic excimer light (308nm) versus monochromatic excimer light (308nm) and 4% khellin extract in treatment of vitiligo.Int. J. Med. Arts202200010.21608/ijma.2022.172771.1544
     [Google Scholar]
  82. DuY. LuoM. DuY. XuM. YaoQ. WangK. HeG. Liquiritigenin decreases Aβ levels and ameliorates cognitive decline by regulating microglia M1/M2 transformation in AD mice.Neurotox. Res.202139234935810.1007/s12640‑020‑00284‑z32990912
     [Google Scholar]
  83. UtoT. OhtaT. YamashitaA. FujiiS. ShoyamaY. Liquiritin and liquiritigenin induce melanogenesis via enhancement of p38 and PKA signaling pathways.Medicines2019626810.3390/medicines6020068
     [Google Scholar]
  84. ZhouJ. ChenF. YanA. XiaX. Madecassoside protects retinal pigment epithelial cells against hydrogen peroxide-induced oxidative stress and apoptosis through the activation of Nrf2/HO-1 pathway.Biosci. Rep.20204010BSR2019434710.1042/BSR2019434733000859
     [Google Scholar]
  85. PengL.Y. ShiH.T. YuanM. LiJ.H. SongK. HuangJ.N. YiP-F. ShenH-Q. FuB-D. Madecassoside protects against LPS-induced acute lung injury via inhibiting TLR4/NF-κB activation and blood-air barrier permeability.Front. Pharmacol.20201180710.3389/fphar.2020.00807
     [Google Scholar]
  86. WangY. LiS. LiC. Perspectives of new advances in the pathogenesis of vitiligo: From oxidative stress to autoimmunity.Med. Sci. Monit.2019251017102310.12659/MSM.91489830723188
     [Google Scholar]
  87. ShenX. GuoM. YuH. LiuD. LuZ. LuY. Propionibacterium acnes related anti-inflammation and skin hydration activities of madecassoside, a pentacyclic triterpene saponin from Centella asiatica.Biosci. Biotechnol. Biochem.201983356156810.1080/09168451.2018.154762730452312
     [Google Scholar]
  88. LingY. GongQ. XiongX. SunL. ZhaoW. ZhuW. LuY. Protective effect of madecassoside on H2O2-induced oxidative stress and autophagy activation in human melanocytes.Oncotarget2017831510665107510.18632/oncotarget.1765428881630
     [Google Scholar]
  89. AlvesF.S. CruzJ.N. de Farias RamosI.N. do Nascimento BrandãoD.L. QueirozR.N. da SilvaG.V. da SilvaG.V. DolabelaM.F. da CostaM.L. KhayatA.S. de Arimatéia Rodrigues do RegoJ. do Socorro Barros BrasilD. Evaluation of antimicrobial activity and cytotoxicity effects of extracts of Piper nigrum L. and piperine. Separations20221012110.3390/separations10010021
     [Google Scholar]
  90. ZahinM. BokhariN.A. AhmadI. HusainF.M. AlthubianiA.S. AlruwaysM.W. PerveenK. ShalawiM. Antioxidant, antibacterial, and antimutagenic activity of Piper nigrum seeds extracts.Saudi J. Biol. Sci.20212895094510510.1016/j.sjbs.2021.05.03034466087
     [Google Scholar]
  91. FaasL. VenkatasamyR. HiderR.C. YoungA.R. SoumyanathA. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.Br. J. Dermatol.2008158594195010.1111/j.1365‑2133.2008.08464.x18284389
     [Google Scholar]
  92. JeonH.J. KimK. KimY.D. LeeS.E. Antimelanogenic activities of piperlongumine derived from Piper longum on murine B16F10 melanoma cells in vitro and zebrafish embryos in vivo: Its molecular mode of depigmenting action.Appl. Biol. Chem.20196216110.1186/s13765‑019‑0468‑7
     [Google Scholar]
  93. YadavS.S. SinghM.K. HussainS. DwivediP. KhattriS. SinghK. Therapeutic spectrum of piperine for clinical practice: A scoping review.Crit. Rev. Food Sci. Nutr.202363225813584010.1080/10408398.2021.202479234996326
     [Google Scholar]
  94. Mahmoud Abd El-Ghany El-DyastyB. Ahmed Abd El-Rahman El-KhalawanyM. Mohamed Abd El-Salam Abd El-KareemI. AuthorC. Evaluation of the efficacy of topical piperine oil combined with excimer light phototherapy in the treatment of non-segmental vitiligo: Comparative intra individual study.Al-Azhar Med J(Medicine)2021501425143210.21608/amj.2021.158624
     [Google Scholar]
  95. TatuA.L. MihailaB. DinicaR. BuziaO.D. RadaschinD.S. NwabudikeL.C. Piperine extract and white patches.Clinical Cases in Dermatology2020103–710310710.1007/978‑3‑030‑50823‑4_22
     [Google Scholar]
  96. JaisinY. RatanachamnongP. WongsawatkulO. WatthammawutA. MalaniyomK. NatewongS. Antioxidant and anti-inflammatory effects of piperine on UV-B-irradiated human- HaCaT keratinocyte cells.Life Sci.202026311860710.1016/j.lfs.2020.11860733091445
     [Google Scholar]
  97. Alvarez-ArellanoL. Salazar-GarcíaM. CoronaJC. Jazvinš´cakM. JembreJ. ŠegotaS. Neuroprotective effects of quercetin in pediatric neurological diseases.Molecules20202523559710.3390/molecules25235597
     [Google Scholar]
  98. GuanC. XuW. HongW. ZhouM. LinF. FuL. LiuD. XuA. Quercetin attenuates the effects of H2O2 on endoplasmic reticulum morphology and tyrosinase export from the endoplasmic reticulum in melanocytes.Mol. Med. Rep.20151164285429010.3892/mmr.2015.324225625855
     [Google Scholar]
  99. Liu-SmithF. MeyskensF.L. Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma.Mol. Nutr. Food Res.20166061264127410.1002/mnfr.20150082226865001
     [Google Scholar]
  100. ChenH. LuC. LiuH. WangM. ZhaoH. YanY. HanL. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.Int. Immunopharmacol.20174811011710.1016/j.intimp.2017.04.02228499194
     [Google Scholar]
  101. ZhangL. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine.Drug Deliv.201926186086910.1080/10717544.2019.1660732
     [Google Scholar]
  102. DingX. MeiE. HuM. ZhouC. LiX. CaiL. LiZ. Effect of puerarin on melanogenesis in human melanocytes and vitiligo mouse models and the underlying mechanism.Phytother. Res.201933120521310.1002/ptr.621830421463
     [Google Scholar]
  103. ParkW. KwonO. YoonT.J. ChungJ.H. Anti-graying effect of the extract of Pueraria thunbergiana via upregulation of cAMP/MITF-M signaling pathway.J. Dermatol. Sci.201475215315510.1016/j.jdermsci.2014.05.00324924521
     [Google Scholar]
  104. ZhouX.L. WanX.M. FuX.X. XieC.G. Puerarin prevents cadmium-induced hepatic cell damage by suppressing apoptosis and restoring autophagic flux.Biomed. Pharmacother.201911510892910.1016/j.biopha.2019.10892931060001
     [Google Scholar]
  105. XieX. ZhongH. XuX. The mRNA expression levels of the Th22 specific transcription factor AHR in patients with vitiligo and its role in vitiligo disease progression.Int. J. Clin. Exp. Med.202114218225
     [Google Scholar]
  106. HeM. MinJ.W. KongW.L. HeX.H. LiJ.X. PengB.W. A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia2016115748510.1016/j.fitote.2016.09.01127693342
     [Google Scholar]
  107. FahmyN.M. Al-SayedE. MoghannemS. AzamF. El-ShazlyM. SingabA.N. Breaking down the barriers to a natural antiviral agent: Antiviral activity and molecular docking of erythrina speciosa extract, fractions, and the major compound.Chem. Biodivers.2020172e190051110.1002/cbdv.20190051131800173
     [Google Scholar]
  108. BabaeiF. MoafizadA. DarvishvandZ. MirzababaeiM. HosseinzadehH. Nassiri-AslM. Review of the effects of vitexin in oxidative stress‐related diseases.Food Sci. Nutr.2020862569258010.1002/fsn3.156732566174
     [Google Scholar]
  109. DasM.C. SandhuP. GuptaP. RudrapaulP. DeU.C. TribediP. AkhterY. BhattacharjeeS. Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin.Sci. Rep.2016612334710.1038/srep2334727000525
     [Google Scholar]
  110. LiX.S. TangX.Y. SuW. LiX. Vitexin protects melanocytes from oxidative stress via activating MAPK-Nrf2/ARE pathway.Immunopharmacol. Immunotoxicol.202042659460310.1080/08923973.2020.183595233045867
     [Google Scholar]
  111. MamatN. LuX. KabasM. AisaH. Potential anti-vitiligo properties of cynarine extracted from Vernonia anthelmintica (L.) Willd.Int. J. Mol. Med.20184252665267510.3892/ijmm.2018.386130226537
     [Google Scholar]
  112. Mir-PalomoS. NácherA. Ofelia Vila BusóM.A. CaddeoC. MancaM.L. ManconiM. Díez-SalesO. Baicalin and berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy.Colloids Surf. B Biointerfaces201917565466210.1016/j.colsurfb.2018.12.05530590326
     [Google Scholar]
  113. JiangW. LiS. ChenX. ZhangW. ChangY. HeY. ZhangS. SuX. GaoT. LiC. JianZ. Berberine protects immortalized line of human melanocytes from H2O2-induced oxidative stress via activation of Nrf2 and Mitf signaling pathway.J. Dermatol. Sci.201994123624310.1016/j.jdermsci.2019.03.00730987854
     [Google Scholar]
  114. Jabbarzadeh KaboliP. RahmatA. IsmailP. LingK.H. Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer.Eur. J. Pharmacol.201474058459510.1016/j.ejphar.2014.06.02524973693
     [Google Scholar]
  115. EhteshamfarS.M. AkhbariM. AfshariJ.T. SeyediM. NikfarB. Shapouri-MoghaddamA. GhanbarzadehE. Momtazi-BorojeniA.A. Anti‐inflammatory and immune‐modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation.J. Cell. Mol. Med.20202423135731358810.1111/jcmm.1604933135395
     [Google Scholar]
  116. 5-fluorouracil for treatment of stable vitiligo. NCT06209138.2024Available from: https://clinicaltrials.gov/study/NCT06209138.
  117. Repigmentation of stable vitiligo lesions using Spray-On Skin™ Cells (TONE). NCT05971381.2025Available from: https://clinicaltrials.gov/study/NCT05971381
  118. A Study to evaluate the mechanism of action of ruxolitinib cream in subjects with vitiligo (TRuE-V MOA). NCT04896385.2025Available from: https://clinicaltrials.gov/study/NCT04896385.
  119. T central memory cells in early localized non-segmental vitiligo. NCT05706636.2025Available from: https://clinicaltrials.gov/study/NCT05706636.
  120. A study of INCB018424 phosphate cream in subjects with vitiligo. NCT03099304.2022Available from: https://clinicaltrials.gov/study/NCT03099304.
  121. Comparitive study between Uvb alone and Uvb with topical tacrolimus 0.03% for the treatment of vitiligo. NCT05577637.2022Available from: https://clinicaltrials.gov/study/NCT05577637.
  122. Enhanced transcutaneous delivery of betamethasone for the treatment of vitiligo. NCT05233735.2022Available from: https://clinicaltrials.gov/study/NCT05233735.
  123. Efficacy and safety of total glucosides of paeony combined with NB-UVB on treating vitiligo. NCT03608917.2021Available from: https://clinicaltrials.gov/study/NCT03608917.
  124. Combined therapy with narrow-band ultraviolet B phototherapy and apremilast for the treatment of vitiligo. NCT03123016.2019Available from: https://clinicaltrials.gov/study/NCT03123016.
  125. To study the efficacy of therapeutic pulsed ultrasound in the treatment of vitiligo: A randomized, intra-individual, left-right comparison study. NCT03864315.2019Available from: https://clinicaltrials.gov/study/NCT03864315.
/content/journals/npj/10.2174/0122103155337960241205070806
Loading
Vitiligo Treatment with Natural Bioactive: A Narrative Review
Natural Products Journal, The 16, e22103155337960 (2026); https://doi.org/10.2174/0122103155337960241205070806
/content/journals/npj/10.2174/0122103155337960241205070806
/content/journals/npj/10.2174/0122103155337960241205070806
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Inflammation modulation; melanocyte protection; natural bioactives; oxidative stress; plant extracts; repigmentation; vitiligo

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test